La Jolla Pharmaceutical Company Profile (NASDAQ:LJPC)

About La Jolla Pharmaceutical

La Jolla Pharmaceutical logoLa Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies to improve outcomes in patients suffering from life-threatening diseases. It is engaged in the research, development and commercialization of its technologies and drug candidates for pharmaceutical products. Its product candidates in development include LJPC-501, LJPC-401, LJPC-30Sa and LJPC-30Sb. The Company is developing LJPC-501 for the treatment of catecholamine-resistant hypotension (CRH). The Company is developing LJPC-401 for the treatment of iron overload, which occurs as a result of diseases, such as hereditary hemochromatosis, beta thalassemia, sickle cell disease and myelodysplastic syndrome. It is developing LJPC-30Sa and LJPC-30Sb not only for the treatment of serious bacterial infections but also for the potential treatment of rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: LJPC
  • CUSIP:
Key Metrics:
  • Previous Close: $19.05
  • 50 Day Moving Average: $17.22
  • 200 Day Moving Average: $17.68
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.19
  • P/E Growth: -0.38
  • Market Cap: $347.74M
  • Outstanding Shares: 18,254,000
  • Beta: 1.8
Additional Links:
Companies Related to La Jolla Pharmaceutical:

Analyst Ratings

Consensus Ratings for La Jolla Pharmaceutical (NASDAQ:LJPC) (?)
Ratings Breakdown: 6 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $42.40 (122.57% upside)

Analysts' Ratings History for La Jolla Pharmaceutical (NASDAQ:LJPC)
Show:
DateFirmActionRatingPrice TargetDetails
6/22/2016SunTrust Banks Inc.Initiated CoverageBuy$30.00View Rating Details
6/8/2016Jefferies GroupReiterated RatingBuyView Rating Details
5/24/2016Lake Street CapitalInitiated CoverageBuy$25.00View Rating Details
2/9/2016Cowen and CompanyInitiated CoverageOutperform$40.00View Rating Details
1/19/2016Noble FinancialReiterated RatingBuy$37.00View Rating Details
9/8/2015Chardan CapitalBoost Price TargetBuy$60.00 -> $80.00View Rating Details
5/11/2015HC WainwrightLower Price TargetBuy$29.00 -> $20.00View Rating Details
4/20/2015Oppenheimer Holdings Inc.Initiated CoverageOutperform$43.00View Rating Details
(Data available from 8/24/2014 forward)

Earnings

Earnings History for La Jolla Pharmaceutical (NASDAQ:LJPC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/4/2016        
8/8/2016Q2($0.99)($0.90)ViewN/AView Earnings Details
5/6/2016Q416($0.74)($0.96)ViewN/AView Earnings Details
11/6/2015Q315($0.71)($0.70)ViewN/AView Earnings Details
8/7/2015Q215($0.61)($0.70)ViewN/AView Earnings Details
3/16/2015Q414($0.37)($0.45)ViewN/AView Earnings Details
11/12/2014Q314($0.31)($0.37)ViewN/AView Earnings Details
8/14/2014Q214($0.69)($0.63)ViewN/AView Earnings Details
5/2/2014($0.91)($0.93)ViewN/AView Earnings Details
3/31/2014($0.24)($0.07)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for La Jolla Pharmaceutical (NASDAQ:LJPC)
Current Year EPS Consensus Estimate: $-3.57 EPS
Next Year EPS Consensus Estimate: $-3.67 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.95)($0.95)($0.95)
Q3 20163($1.00)($0.97)($0.98)
Q4 20163($1.08)($0.77)($0.95)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for La Jolla Pharmaceutical (NASDAQ:LJPC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for La Jolla Pharmaceutical (NASDAQ:LJPC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/4/2016Kevin C TangDirectorBuy20,000$19.85$397,000.00View SEC Filing  
3/1/2016George F TidmarshCEOBuy2,000$16.57$33,140.00View SEC Filing  
9/28/2015Lakhmir S ChawlaInsiderBuy485$27.75$13,458.75View SEC Filing  
9/10/2015Kevin C TangDirectorBuy80,000$38.00$3,040,000.00View SEC Filing  
8/21/2015Kevin C TangDirectorBuy170,000$27.11$4,608,700.00View SEC Filing  
6/26/2015Kevin C TangDirectorBuy110,000$23.58$2,593,800.00View SEC Filing  
6/24/2015Kevin C TangDirectorBuy220,000$22.23$4,890,600.00View SEC Filing  
6/23/2015Kevin C TangDirectorBuy53,836$22.27$1,198,927.72View SEC Filing  
6/22/2015Kevin C TangDirectorBuy77,850$21.41$1,666,768.50View SEC Filing  
5/13/2015Kevin C TangDirectorBuy190,583$18.24$3,476,233.92View SEC Filing  
5/12/2015George F TidmarshCEOBuy4,000$18.37$73,480.00View SEC Filing  
12/15/2014Kevin C TangDirectorBuy232,343$12.84$2,983,284.12View SEC Filing  
12/11/2014George F TidmarshCEOBuy4,000$11.38$45,520.00View SEC Filing  
9/26/2014George F TidmarshCEOBuy2,000$9.35$18,700.00View SEC Filing  
9/26/2014Kevin C TangDirectorBuy169,555$9.14$1,549,732.70View SEC Filing  
9/25/2014Kevin C TangDirectorBuy30,500$9.17$279,685.00View SEC Filing  
9/24/2014Kevin C TangDirectorBuy95,000$9.10$864,500.00View SEC Filing  
9/18/2014George F TidmarshCEOBuy5,000$9.18$45,900.00View SEC Filing  
7/23/2014George F TidmarshCEOBuy19,000$10.50$199,500.00View SEC Filing  
5/21/2014George TidmarshCEOBuy12,000$7.37$88,440.00View SEC Filing  
4/14/2014George TidmarshCEOBuy8,000$9.53$76,240.00View SEC Filing  
2/7/2014George F TidmarshCEOBuy3,000$7.25$21,750.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for La Jolla Pharmaceutical (NASDAQ:LJPC)
DateHeadline
News IconTSRI study supports new strategy to fight cocaine addiction (NASDAQ:LJPC)
www.sciencecodex.com - August 19 at 5:55 PM
News IconTSRI Scientists Find Potential Treatment for 'Painful Blindness' Form of Dry Eye (NASDAQ:LJPC)
sciencenewsline.com - August 19 at 5:55 PM
News IconLa Jolla (NASDAQ:LJPC)
www.onenewspage.com - August 18 at 9:00 AM
finance.yahoo.com logoLA JOLLA PHARMACEUTICAL CO Financials (NASDAQ:LJPC)
finance.yahoo.com - August 17 at 6:09 PM
kcregister.com logoShining on Major News: La Jolla Pharmaceutical Co. (NASDAQ:LJPC), Chimerix, Inc. (NASDAQ:CMRX), YY Inc ... - KC Register (NASDAQ:LJPC)
www.kcregister.com - August 16 at 9:16 AM
investornewswire.com logoWill La Jolla Pharmaceutical Company (NASDAQ:LJPC) Hit $80 Price Target? - Investor Newswire (NASDAQ:LJPC)
www.investornewswire.com - August 16 at 9:16 AM
biz.yahoo.com logoLA JOLLA PHARMACEUTICAL CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an (NASDAQ:LJPC)
biz.yahoo.com - August 12 at 6:04 PM
finance.yahoo.com logoLa Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, … (NASDAQ:LJPC)
finance.yahoo.com - August 9 at 6:09 PM
businesswire.com logoLa Jolla Pharmaceutical Company Announces Financial Results for ... - Business Wire (press release) (NASDAQ:LJPC)
www.businesswire.com - August 9 at 9:00 AM
publicnow.com logoLa Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2016 (NASDAQ:LJPC)
www.publicnow.com - August 9 at 9:00 AM
sg.finance.yahoo.com logoLa Jolla Pharmaceutical posts 2Q loss (NASDAQ:LJPC)
sg.finance.yahoo.com - August 8 at 6:11 PM
investornewswire.com logoCan Shares Of La Jolla Pharmaceutical Company (NASDAQ:LJPC) Hit $80? - Investor Newswire (NASDAQ:LJPC)
www.investornewswire.com - July 26 at 9:00 AM
News IconLa Jolla Pharmaceutical Company Therapeutics and Product Pipeline Review H1 2016 (NASDAQ:LJPC)
www.medgadget.com - July 23 at 9:55 AM
4-traders.com logoLa Jolla Pharmaceutical Company : Therapeutics strategies and Product Pipeline Review 2016 (NASDAQ:LJPC)
www.4-traders.com - July 23 at 9:55 AM
News IconLa Jolla Pharmaceutical Company (NASDAQ:LJPC): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:LJPC)
www.engelwooddaily.com - July 22 at 8:55 AM
News IconLa Jolla Pharmaceutical Company Can't Burn Your Long Portfolio. Has Another Strong Session - Consumer Eagle (NASDAQ:LJPC)
www.consumereagle.com - July 21 at 12:06 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for La Jolla Pharmaceutical Company (NASDAQ:LJPC) - TGP (NASDAQ:LJPC)
telanaganapress.com - July 20 at 4:05 PM
investornewswire.com logoIs $80 Price Target Attainable For La Jolla Pharmaceutical Company (NASDAQ:LJPC)? - Investor Newswire (NASDAQ:LJPC)
www.investornewswire.com - July 20 at 4:05 PM
News IconEquity Roundup: Stock Performance Focus on La Jolla Pharmaceutical Company (NASDAQ:LJPC) - Press Telegraph (NASDAQ:LJPC)
presstelegraph.com - July 20 at 4:05 PM
capitalcube.com logoLa Jolla Pharmaceutical Co. – Value Analysis (NASDAQ:LJPC) : July 18, 2016 (NASDAQ:LJPC)
www.capitalcube.com - July 18 at 3:57 PM
ftsenews.co.uk logoLa Jolla Pharmaceutical Company (LJPC) Updated Price Targets - FTSE News (NASDAQ:LJPC)
www.ftsenews.co.uk - July 18 at 11:14 AM
News IconAre Analysts Bullish La Jolla Pharmaceutical Company (NASDAQ:LJPC) After Last Week? - Consumer Eagle (NASDAQ:LJPC)
www.consumereagle.com - July 18 at 11:14 AM
News IconShares Experiencing a Downtrend: La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - TGP (NASDAQ:LJPC)
telanaganapress.com - July 16 at 5:38 PM
News IconShares Moving Down on the Week: La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Engelwood Daily (NASDAQ:LJPC)
www.engelwooddaily.com - July 16 at 5:38 PM
News IconTang Capital Management LLC Increased La Jolla Pharmaceutical Co (NASDAQ:LJPC) by $3.60 Million as Shares ... - Consumer Eagle (NASDAQ:LJPC)
www.consumereagle.com - July 16 at 5:38 PM
News IconLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:LJPC)
www.engelwooddaily.com - July 15 at 10:10 AM
fiscalstandard.com logoBroker Outlook For La Jolla Pharmaceutical Company (LJPC) - Fiscal Standard (NASDAQ:LJPC)
www.fiscalstandard.com - July 14 at 6:11 PM
News IconAnalyst Target and Average Rating Watch: La Jolla Pharmaceutical Company (NASDAQ:LJPC) - Press Telegraph (NASDAQ:LJPC)
presstelegraph.com - July 14 at 9:34 AM
News IconInsiders Increasing Positions in: La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Press Telegraph (NASDAQ:LJPC)
presstelegraph.com - July 14 at 9:34 AM
News IconLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:LJPC)
telanaganapress.com - July 12 at 10:21 AM
News IconWere Analysts Bearish La Jolla Pharmaceutical Company (NASDAQ:LJPC) This Week? - Press Telegraph (NASDAQ:LJPC)
presstelegraph.com - July 11 at 5:59 PM
investornewswire.com logoStrong Sell Calls For La Jolla Pharmaceutical Company (NASDAQ:LJPC) At 0 - Investor Newswire (NASDAQ:LJPC)
www.investornewswire.com - July 11 at 5:59 PM
capitalcube.com logoLa Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : July 11, 2016 (NASDAQ:LJPC)
www.capitalcube.com - July 11 at 8:14 AM
fiscalstandard.com logoLa Jolla Pharmaceutical Company (LJPC) Current Analyst Ratings - Fiscal Standard (NASDAQ:LJPC)
www.fiscalstandard.com - July 8 at 8:53 AM
News IconStock Tracking Down This Month; Investor Alert on La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Engelwood Daily (NASDAQ:LJPC)
www.engelwooddaily.com - July 7 at 8:52 AM
News IconCompany Stock Focus for La Jolla Pharmaceutical Company (NASDAQ:LJPC): Which Way Will Shares Head? - Press Telegraph (NASDAQ:LJPC)
presstelegraph.com - July 7 at 8:52 AM
ftsenews.co.uk logoNew Broker Ratings For La Jolla Pharmaceutical Company (LJPC) - FTSE News (NASDAQ:LJPC)
www.ftsenews.co.uk - July 6 at 10:38 AM
fiscalstandard.com logoRecently Issued Stock Ratings For La Jolla Pharmaceutical Company (LJPC) - Fiscal Standard (NASDAQ:LJPC)
www.fiscalstandard.com - July 2 at 8:50 AM
News IconTang Capital Management LLC Increased La Jolla Pharmaceutical Co (NASDAQ:LJPC) by $3.60 Million as Shares ... - Press Telegraph (NASDAQ:LJPC)
presstelegraph.com - July 2 at 8:50 AM
News IconCovering the Bases on La Jolla Pharmaceutical Company (NASDAQ:LJPC): Where is the Stock Going? - Press Telegraph (NASDAQ:LJPC)
presstelegraph.com - June 30 at 8:52 AM
news.cmlviz.com logoLa Jolla Pharmaceutical Co. Stock Momentum at Critical Inflection Point - CML News (NASDAQ:LJPC)
news.cmlviz.com - June 29 at 5:51 PM
News IconLa Jolla Pharmaceutical Company on Focus After Forming Multiple Bottom Chart Pattern - Press Telegraph (NASDAQ:LJPC)
presstelegraph.com - June 29 at 5:51 PM
fiscalstandard.com logoBroker Outlook For The Week Ahead La Jolla Pharmaceutical Company (LJPC) - Fiscal Standard (NASDAQ:LJPC)
www.fiscalstandard.com - June 29 at 8:48 AM
investornewswire.com logoStrong Sell Calls Recommendations For La Jolla Pharmaceutical Company (NASDAQ:LJPC) At 0 - Investor Newswire (NASDAQ:LJPC)
www.investornewswire.com - June 29 at 8:48 AM
capitalcube.com logoLa Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : June 27, 2016 (NASDAQ:LJPC)
www.capitalcube.com - June 27 at 8:27 AM
News IconShare Volatility Check for: La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Press Telegraph (NASDAQ:LJPC)
presstelegraph.com - June 24 at 5:57 PM
News IconLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:LJPC)
www.engelwooddaily.com - June 24 at 8:37 AM
schaeffersresearch.com logoAnalyst Update: T2 Biosystems Inc, La Jolla Pharmaceutical Company, and Illumina, Inc. (NASDAQ:LJPC)
www.schaeffersresearch.com - June 22 at 4:02 PM
investornewswire.com logoStrong Buy Calls Count For La Jolla Pharmaceutical Company (NASDAQ:LJPC) At 5 - Investor Newswire (NASDAQ:LJPC)
www.investornewswire.com - June 21 at 5:38 PM
fiscalstandard.com logoLa Jolla Pharmaceutical Company (LJPC) Analyst Price Targets For The Coming Week - Fiscal Standard (NASDAQ:LJPC)
www.fiscalstandard.com - June 20 at 8:09 AM

Social

La Jolla Pharmaceutical (NASDAQ:LJPC) Chart for Wednesday, August, 24, 2016


Last Updated on 8/24/2016 by MarketBeat.com Staff